Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Singapore Moves Upstream In The Medtech Value Chain

This article was originally published in Clinica

Executive Summary

Singapore set out to build a knowledge-based economy some 25 years ago and biomedical sciences have been a key focus of successive five-year R&D funding initiatives. In this article exploring Singapore’s R&D landscape – including insights from key decision-makers and innovators – Tina Tan talks to executives of Exploit Technologies Pte Ltd. (ETPL), the commercialization arm of the country’s science and technology agency, A*STAR, on their models for engaging the different players in the innovation ecosystem. She also delves into one of Singapore’s research institutes, the Institute of Bioengineering and Nanotechnology, to find out what academia-industry collaborations are being forged there


Related Content

From Small Republics Big Ideas Grow





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts